Petkovich; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Petkovich; Martin.The latest application filed is for "compounds and methods for inhibiting cpy26 enzymes".

Company Profile

4.9.7

Petkovich; Martin - Kingston CA
Petkovich; Martin - Strasbourg FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods for inhibiting CPY26 enzymes Grant 11,364,220 - Cameron , et al. June 21, 2	2022-06-21
Compounds and methods for inhibiting CYP26 enzymes Grant 11,358,933 - Cameron , et al. June 14, 2	2022-06-14
Compounds and Methods for Inhibiting CPY26 Enzymes App 20210220326 - Cameron; Donald Andrew ; et al.	2021-07-22
Compounds and Methods for Inhibiting CYP26 Enzymes App 20210107870 - Cameron; Donald Andrew ; et al.	2021-04-15
Compounds and methods for inhibiting CYP26 enzymes Grant 10,874,634 - Cameron , et al. December 29, 2	2020-12-29
Compounds and Methods for Inhibiting CYP26 Enzymes App 20200369609 - Cameron; Donald Andrew ; et al.	2020-11-26
Compounds and Methods for Inhibiting CPY26 Enzymes App 20200093788 - Cameron; Donald Andrew ; et al.	2020-03-26
Methods of reducing phosphate absorption Grant 8,877,198 - Cook , et al. November 4, 2	2014-11-04
Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody Grant 8,802,094 - Cook , et al. August 12, 2	2014-08-12
Methods Of Reducing Phosphate Absorption App 20100233184 - Cook; Mark ; et al.	2010-09-16
Methods Of Reducing Phosphate Absorption App 20100166760 - Cook; Mark ; et al.	2010-07-01
Methods For Reducing Phosphate Absorption App 20100143385 - Cook; Mark ; et al.	2010-06-10
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor Grant 5,376,530 - De The , et al. December 27, 1	1994-12-27
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor Grant 5,317,090 - Blaudin De The , et al. May 31, 1	1994-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.